ライフサイエンスコーパス: cardiopulmonary

1 nicotine vapor self-administration produced cardiopulmonary abnormalities and changes in alpha4, alp

2 s translating into improved musculoskeletal, cardiopulmonary and cerebrovascular function.

3 The adjusted odds ratios of cardiopulmonary and noncardiopulmonary complications, in

4 moderate altitude exacerbates SCD associated cardiopulmonary and systemic complications.

5 o restore oxygenation and reduce the risk of cardiopulmonary arrest.

6 on to conventional surgery (0.6%) and use of cardiopulmonary bypass (0.7%) were rare.

7 hat leukocytes of patients with T2D or after cardiopulmonary bypass (CPB) expressed similar SI.

8 The use of cardiopulmonary bypass (CPB) results in the activation o

9 The MHCA + SACP group had shorter cardiopulmonary bypass (CPB) time (146.9 +/- 40.6 vs 189

10 We developed a porcine model of infant cardiopulmonary bypass (CPB) with deep hypothermic circu

11 nic artificial surfaces, for example, during cardiopulmonary bypass (CPB), induces a highly procoagul

12 e cardiac surgery with the implementation of cardiopulmonary bypass (CPB).

13 CABG was performed with or without cardiopulmonary bypass (on-pump vs. off-pump surgery) ac

14 T1 correlated with RV T1 (r=0.45, P<0.001), cardiopulmonary bypass (r=0.30, P=0.007), and aortic cro

15 in-induced thrombocytopenia in patients post cardiopulmonary bypass and on extracorporeal membrane ox

16 ssue obtained from patients before and after cardiopulmonary bypass and reperfusion and left ventricu

17 ney injury) in high-risk patients undergoing cardiopulmonary bypass and that the protective effect is

18 Neonates undergoing cardiac surgery with cardiopulmonary bypass at 2 centers were enrolled in a d

19 the extracorporeal membrane oxygenation and cardiopulmonary bypass cohorts was 45.4 (+/- 15.6) and 6

20 ey injury in infants and children undergoing cardiopulmonary bypass for cardiac surgery.

21 as conducted to elucidate mechanisms of post-cardiopulmonary bypass immunosuppression.

22 Cardiopulmonary bypass is associated with severe immune

23 Thrombocytopenia increased in cardiopulmonary bypass patients on day 2 but was normal

24 atically increased arginase-1 levels in post-cardiopulmonary bypass peripheral blood mononuclear cell

25 f myeloid-derived suppressor cells from post-cardiopulmonary bypass peripheral blood mononuclear cell

26 cardiac surgery, since it is recognized that cardiopulmonary bypass presents many precipitating risk

27 eline and after 20 min CA followed by 30 min cardiopulmonary bypass resuscitation.

28 Cardiopulmonary bypass strongly impairs the adaptive imm

29 tinal bleeding is common following pediatric cardiopulmonary bypass surgery for congenital heart dise

30 led trial on infants 2.5 to 12 kg undergoing cardiopulmonary bypass surgery, aimed at (1) demonstrati

31 levant condition of systemic sterile stress, cardiopulmonary bypass surgery, we confirmed the initial

32 corporeal membrane oxygenation compared with cardiopulmonary bypass throughout (p < 0.0001).

33 e 139.8] versus 412.8 [132] min, P < 0.001), cardiopulmonary bypass time (220 [63] versus 176 [73] mi

34 Men experienced longer cross-clamp and cardiopulmonary bypass times, but similar durations of c

35 Median duration of cardiopulmonary bypass was 4.6 hours (2-16.5 hr) compare

36 a in extracorporeal membrane oxygenation and cardiopulmonary bypass were 6.4% (19/298) and 0.6% (18/2

37 ral blood mononuclear cells before and after cardiopulmonary bypass were analyzed for the expression

38 Patients who had had cardiac surgery with cardiopulmonary bypass were enrolled.

39 531 patients undergoing cardiac surgery with cardiopulmonary bypass who had a moderate-to-high risk o

40 ficant bleeding and hypofibrinogenemia after cardiopulmonary bypass, fibrinogen concentrate is noninf

41 After cardiopulmonary bypass, peripheral blood mononuclear cel

42 Particularly, a cardiopulmonary bypass-related long-lasting immunosuppre

43 d no acute conversion to surgery or need for cardiopulmonary bypass.

44 for each ordered dose within 24 hours after cardiopulmonary bypass.

45 e onset of immunoparalysis in the setting of cardiopulmonary bypass.

46 hile patient is hemodynamically supported on cardiopulmonary bypass.

47 drome in 31.3%, and 95.2% of procedures used cardiopulmonary bypass.

48 corporeal membrane oxygenation compared with cardiopulmonary bypass.

49 untreated animals) in a clinically relevant cardiopulmonary-bypass model in sheep.

50 , nonaccidental (stratified by age and sex), cardiopulmonary, cardiovascular, and respiratory mortali

51 alysis controlling for age, gender, obesity, cardiopulmonary comorbidities, hypertension, and diabete

52 older age, smoking habits, and pre-existing cardiopulmonary comorbidities, in addition to cancer tre

53 Despite cardiopulmonary complications not being statistically di

54 er percentage of overall surgery-related and cardiopulmonary complications with lower postoperative p

55 who underwent noncardiac surgery, 41.1% had cardiopulmonary complications, 55.7% had noncardiopulmon

56 importance of ruling out infection and other cardiopulmonary conditions before making a presumptive d

57 ne healthy sedentary individuals free of any cardiopulmonary disease (42 +/- 12 years, 78 +/- 11 kg),

58 Although prematurity and cardiopulmonary disease are risk factors for severe dise

59 d donation (including infection, malignancy, cardiopulmonary disease) and uDCD (including hemorrhage,

60 me in this cohort of patients with PE and no cardiopulmonary disease, and it may provide a simple sin

61 lmonary perfusion, which may be disrupted by cardiopulmonary disease, but this is not well studied, p

62 latory mechanisms, which may be disrupted by cardiopulmonary disease, but this is not well studied, p

63 group A) or absence (group B) of preexisting cardiopulmonary disease.

64 e matter < 2.5u (PM(2.5)) has been linked to cardiopulmonary disease.

65 ary arterial hypertension is a severe lethal cardiopulmonary disease.

66 in 30 dogs with persistent cyanosis without cardiopulmonary disease.

67 lmonary embolism (PE) is a potentially fatal cardiopulmonary disease; therefore, rapid risk stratific

68 After excluding participants with baseline cardiopulmonary diseases, stroke and cancer, 178,485 men

69 have recognized PM(2.5) as a risk factor for cardiopulmonary diseases.

70 nary hypertension (PH) is a life-threatening cardiopulmonary disorder in which inflammation and immun

71 Latinx patients were younger, had fewer cardiopulmonary disorders, were more likely to have obes

72 ng in the reduction or mitigation of adverse cardiopulmonary distress associated with nanopharmaceuti

73 Sickle cell disease (SCD) results in cardiopulmonary dysfunction, which may be exacerbated by

74 pneumonitis, pleural effusion, atelectasis, cardiopulmonary edema, and pneumothorax.

75 This study sought to assess the cardiopulmonary effect of chronic exposure to unmodified

76 The cardiopulmonary effects and molecular mechanisms in anim

77 utritional supplementation can blunt adverse cardiopulmonary effects induced by acute air pollution e

78 rther work is needed to define the long-term cardiopulmonary effects of e-cigarette use in humans.

79 We examined the cardiopulmonary effects of short-term exposure to [Formu

80 e discovered biological pathways involved in cardiopulmonary exercise response and developed predicti

81 underwent an echocardiographic (n = 73) and cardiopulmonary exercise test (n = 37) within 30 days we

82 Cardiopulmonary exercise test and 6-minute walking test

83 ients with VSD aged 12 to 60 years underwent cardiopulmonary exercise test and echocardiography 1 day

84 study was to assess for association between cardiopulmonary exercise test performance at 1 year afte

85 nters, participants also undergo an invasive cardiopulmonary exercise test to assess changes in hemod

86 healthy controls performed a maximal graded cardiopulmonary exercise test with continuous measuremen

87 ion fraction, peak oxygen consumption in the cardiopulmonary exercise test, 6-min walk test, and qual

88 fraction <45%, stable conditions) underwent cardiopulmonary exercise test.

89 The prognostic value of cardiopulmonary exercise testing (CPET) for survival in

90 Cardiopulmonary exercise testing (CPET) was used to obje

91 ients with HFpEF (8 men, 12 women) underwent cardiopulmonary exercise testing (peak Vo(2)) and static

92 Cardiopulmonary exercise testing and metabolite profilin

93 Biomarkers and cardiopulmonary exercise testing are well validated in t

94 Overall 243 HTx recipients performed cardiopulmonary exercise testing at 1 year after HTx.

95 Laboratory-based cardiopulmonary exercise testing coupled with serial phl

96 years, 78 +/- 11 kg), who completed invasive cardiopulmonary exercise testing during upright ergometr

97 Cardiopulmonary exercise testing is feasible in children

98 These findings suggest that cardiopulmonary exercise testing may be a useful tool to

99 Routine cardiopulmonary exercise testing may be a useful tool to

100 g listed for liver transplantation underwent cardiopulmonary exercise testing to determine ventilator

101 nd preserved ejection fraction who underwent cardiopulmonary exercise testing with invasive hemodynam

102 on fraction >=50% referred for comprehensive cardiopulmonary exercise testing with invasive hemodynam

103 All participants underwent echocardiography, cardiopulmonary exercise testing, 6-minute walking test,

104 ement electrocardiography, echocardiography, cardiopulmonary exercise testing, and genetic testing in

105 hold, a parameter that can be defined during cardiopulmonary exercise testing, but rise rapidly at hi

106 ysis of the right ventricle, during invasive cardiopulmonary exercise testing, demonstrates that that

107 ontan palliation (n = 29) underwent invasive cardiopulmonary exercise testing, echocardiography, and

108 bstruction; and in a subset of patients with cardiopulmonary exercise testing, ischemia burden was as

109 then had pre-randomisation assessments with cardiopulmonary exercise testing, symptom questionnaires

110 k oxygen uptake < 85% predicted from maximal cardiopulmonary exercise testing; organ functions were a

111 Maximum incremental cardiopulmonary exercise tests were performed.

112 icipants were recruited and each underwent 4 cardiopulmonary exercise tests: one incremental and thre

113 , to more widespread use in diverse forms of cardiopulmonary failure in all ages.

114 MO is particularly effective if the cause of cardiopulmonary failure is recognized promptly and is th

115 loss of ambulation and premature death from cardiopulmonary failure.

116 fective treatment for patients with advanced cardiopulmonary failure.

117 able rescue strategy in patients with severe cardiopulmonary failure.

118 esting (CPET) was used to objectively assess cardiopulmonary fitness at baseline and after 6 weeks of

119 body fat, visceral fat mass, lean body mass, cardiopulmonary fitness, physical activity, alcohol cons

120 any will experience a progressive decline in cardiopulmonary function leading to advanced heart failu

121 We examined cardiopulmonary hospitalizations among adults [Formula:

122 ncreased risk of [Formula: see text]-related cardiopulmonary hospitalizations was similar on smoke an

123 usions from an expert workshop, Reducing the Cardiopulmonary Impact of Particulate Matter Air Polluti

124 eal membrane oxygenation provides short-term cardiopulmonary life support, but is associated with per

125 When cardiopulmonary limitations to exercise are minimized, t

126 he same households to evaluate indicators of cardiopulmonary, metabolic, and cancer outcomes.

127 were consistently positive for all-cause and cardiopulmonary mortality across key modeling choices an

128 e text] exposure and daily nonaccidental and cardiopulmonary mortality based on data from 272 cities

129 The excess risk of all-cause and cardiopulmonary mortality fell by more than 60% in 5 yea

130 [Formula: see text] exposure contributes to cardiopulmonary mortality risk.

131 Particulate matter (PM) air pollution causes cardiopulmonary mortality via macrophage-driven lung inf

132 All-cause and cardiopulmonary mortality were identified through linkag

133 use mortality, 1.23 (95% CI: 1.17, 1.29) for cardiopulmonary mortality, and 1.12 (95% CI: 1.00, 1.26)

134 indicates that air pollution contributes to cardiopulmonary mortality.

135 reserve Klotho levels, may improve long-term cardiopulmonary outcomes in preterm infants.

136 assive conduit, but actively participates in cardiopulmonary performance during exercise by accessing

137 studies published to date and summarize the cardiopulmonary physiological changes caused by vaping.

138 ctomy is associated with profound changes in cardiopulmonary physiology.

139 circuit recruited by the recently identified cardiopulmonary progenitors to coordinate morphogenesis

140 onary resuscitation (7/10) than depth-guided cardiopulmonary resuscitation (1/12; p = 0.006).

141 versus 65.3 years), received less bystander cardiopulmonary resuscitation (49.1% versus 54.9%), and

142 me was more likely with hemodynamic-directed cardiopulmonary resuscitation (7/10) than depth-guided c

143 Bystander cardiopulmonary resuscitation (B-CPR) delivery and survi

144 n improves outcomes after cardiac arrest and cardiopulmonary resuscitation (CA/CPR).

145 donors with a history of cardiac arrest and cardiopulmonary resuscitation (CACPR) leads to inferior

146 p) holds the potential to increase bystander cardiopulmonary resuscitation (CPR) and defibrillation i

147 This 2020 International Consensus on Cardiopulmonary Resuscitation (CPR) and Emergency Cardio

148 Early access to 9-1-1 and early cardiopulmonary resuscitation (CPR) are the first 2 link

149 lity, but the extent of staff involvement in cardiopulmonary resuscitation (CPR) efforts and its asso

150 Cardiopulmonary resuscitation (CPR) is initiated in hosp

151 of-hospital cardiac arrest receive bystander cardiopulmonary resuscitation (CPR) less often than men.

152 ide a paradigm when it is ethical to perform cardiopulmonary resuscitation (CPR) on patients during t

153 e emergency response system, early bystander cardiopulmonary resuscitation (CPR) with an emphasis on

154 End-tidal CO(2) (EtCO(2)) is used to monitor cardiopulmonary resuscitation (CPR), but it can be affec

155 review of the effects of dispatcher-assisted cardiopulmonary resuscitation (DA-CPR) on survival of in

156 However, the ability of extracorporeal cardiopulmonary resuscitation (ECPR) to modulate this de

157 duce cooling, primarily of the brain, during cardiopulmonary resuscitation (ie, intra-arrest).

158 d treatment with either hemodynamic-directed cardiopulmonary resuscitation (n = 10; compression depth

159 fusion pressure >= 20 mm Hg) or depth-guided cardiopulmonary resuscitation (n = 12; depth 1/3 chest d

160 variate regression identified extracorporeal cardiopulmonary resuscitation (odds ratio, 3.674; 95% CI

161 (UMN) ECPR protocol (transport with ongoing cardiopulmonary resuscitation [CPR] to the cardiac cathe

162 ation with 1) arterial blood pressure during cardiopulmonary resuscitation and 2) survival outcomes.

163 ST, 224 (55.7%) patients had chosen to limit cardiopulmonary resuscitation and 214 (53.2%) had chosen

164 d the number of BLS (firefighters performing cardiopulmonary resuscitation and applying automated ext

165 mendations on the use of dispatcher-assisted cardiopulmonary resuscitation and cardiac arrest centers

166 20 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascul

167 rican Heart Association (AHA) Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascul

168 This 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascul

169 on Resuscitation International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascul

170 This 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascul

171 This 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascul

172 For this 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascul

173 Control Corporation, Redmond, WA) mechanical cardiopulmonary resuscitation and impedance threshold de

174 ent on the length of cardiac arrest prior to cardiopulmonary resuscitation and is mediated by myocard

175 nvolved in the application of extracorporeal cardiopulmonary resuscitation and its potential impact o

176 oped acute brain injury after extracorporeal cardiopulmonary resuscitation and the most common type w

177 y resuscitation versus standard depth-guided cardiopulmonary resuscitation and to compare brain and h

178 We examined views on cardiopulmonary resuscitation and withholding/withdrawin

179 fing; and the use of social media to improve cardiopulmonary resuscitation application.

180 ients and 33% of the patients had history of cardiopulmonary resuscitation before ECLS implantation.

181 nd with greater than or equal to 1 minute of cardiopulmonary resuscitation before venoarterial extrac

182 lmonary resuscitation, extension of advanced cardiopulmonary resuscitation beyond futility for organ

183 The head-up/torso-up cardiopulmonary resuscitation bundle was feasible and as

184 Post-cardiopulmonary resuscitation cardiac dysfunction was no

185 emergency medical services arrival, and some cardiopulmonary resuscitation characteristics, but were

186 lude the immediate provision of high-quality cardiopulmonary resuscitation combined with rapid defibr

187 red that duration of cardiac arrest prior to cardiopulmonary resuscitation determined postresuscitati

188 iation seems more predictive of outcome than cardiopulmonary resuscitation duration or absence of ret

189 Median cardiopulmonary resuscitation duration was 21 minutes (i

190 The median extracorporeal cardiopulmonary resuscitation duration was 3.2 days (int

191 ed airways, vasopressors, and extracorporeal cardiopulmonary resuscitation during cardiac arrest.

192 ters should offer and instruct bystanders in cardiopulmonary resuscitation during out-of-hospital car

193 suggested that women are inferior leaders of cardiopulmonary resuscitation efforts.

194 In particular, measurement of cardiopulmonary resuscitation elements and neurological

195 t and pediatric patients with a nonpulseless cardiopulmonary resuscitation event from 2000 to 2018.

196 Longer time from onset of the cardiopulmonary resuscitation event to extracorporeal me

197 insufficiency, longer time from onset of the cardiopulmonary resuscitation event to extracorporeal me

198 The median time from onset of the cardiopulmonary resuscitation event to extracorporeal me

199 51%) had subsequent pulselessness during the cardiopulmonary resuscitation event.

200 l blood pressures between children receiving cardiopulmonary resuscitation for bradycardia and poor p

201 utcome 1 year after receiving extracorporeal cardiopulmonary resuscitation for in-hospital arrest.

202 iac arrests and pediatric patients requiring cardiopulmonary resuscitation for poor perfusion (nonpul

203 Cardiogenic shock following cardiopulmonary resuscitation for sudden cardiac arrest

204 ic patients (<=18 years of age) who received cardiopulmonary resuscitation from January 2000 to Decem

205 ction of the 2010 American Heart Association cardiopulmonary resuscitation guidelines in the United S

206 he change in 2010 American Heart Association cardiopulmonary resuscitation guidelines was associated

207 ation of the 2010 American Heart Association cardiopulmonary resuscitation guidelines, 1.25% ([95% CI

208 nge in survival trends before and after 2010 cardiopulmonary resuscitation guidelines.

209 iation/Emergency Cardiovascular Care updated cardiopulmonary resuscitation guidelines.

210 Extracorporeal cardiopulmonary resuscitation has shown survival benefit

211 Hemodynamic-directed cardiopulmonary resuscitation improves short-term surviv

212 ry resuscitation, the role of extracorporeal cardiopulmonary resuscitation in adults and children, va

213 Most children receiving cardiopulmonary resuscitation in ICUs had an initial rhy

214 in pediatric cardiac arrest, extracorporeal cardiopulmonary resuscitation in pediatric cardiac arres

215 has improved for pediatric events requiring cardiopulmonary resuscitation in the United States, with

216 diatric cardiac arrest, hemodynamic-directed cardiopulmonary resuscitation increases rates of 24-hour

217 tients who progressed to pulselessness after cardiopulmonary resuscitation initiation had lower intra

218 e the quality of chest compressions, shorten cardiopulmonary resuscitation interruptions, guide resus

219 tation guideline recommendations to minimize cardiopulmonary resuscitation interruptions.

220 ly, trained physicians can lead high-quality cardiopulmonary resuscitation irrespective of gender.

221 ts, real life female physician leadership of cardiopulmonary resuscitation is not associated with inf

222 partially be explained by fewer unsolicited cardiopulmonary resuscitation measures and inferior fema

223 Pre-operative cardiopulmonary resuscitation occurred in 43.2% of patie

224 re female and male code leaders in regard to cardiopulmonary resuscitation outcomes in a real-world c

225 One in four extracorporeal cardiopulmonary resuscitation patients achieved good neu

226 Among extracorporeal cardiopulmonary resuscitation patients, the median age w

227 training and rapid response teams; measuring cardiopulmonary resuscitation performance, feedback devi

228 ences, with female rescuers showing inferior cardiopulmonary resuscitation performance, which can par

229 odds ratio for each 5 additional minutes of cardiopulmonary resuscitation prior to extracorporeal me

230 te ischemic cardiomyopathy and 66% underwent cardiopulmonary resuscitation prior to venoarterial extr

231 bundled approach including use of mechanical cardiopulmonary resuscitation provided at a head-up angl

232 ender of code leader was not associated with cardiopulmonary resuscitation quality.

233 thors used data from SWEDEHEART, the Swedish Cardiopulmonary Resuscitation Registry, and the Swedish

234 Outcomes after extracorporeal cardiopulmonary resuscitation reported by linking two na

235 Hemodynamic-directed cardiopulmonary resuscitation resulted in higher intra-a

236 Hemodynamic-directed cardiopulmonary resuscitation resulted in higher OXPHOSC

237 radycardia and poor perfusion as the initial cardiopulmonary resuscitation rhythm.

238 on has initiated a near-continuous review of cardiopulmonary resuscitation science that replaces the

239 uous review of new, peer-reviewed, published cardiopulmonary resuscitation science.

240 teams are readily available, extracorporeal cardiopulmonary resuscitation should be considered for p

241 remained more frequent in nonextracorporeal cardiopulmonary resuscitation venoarterial extracorporea

242 iac arrest treated with hemodynamic-directed cardiopulmonary resuscitation versus standard depth-guid

243 e overall survival rate after extracorporeal cardiopulmonary resuscitation was 29% (95% CI, 0.26-0.33

244 Cardiopulmonary resuscitation was ongoing during REBOA i

245 36% strongly agreed with declining to offer cardiopulmonary resuscitation when not indicated.

246 sociate ventilation rates during in-hospital cardiopulmonary resuscitation with 1) arterial blood pre

247 us circulation after three shocks, automated cardiopulmonary resuscitation with a Lund University Car

248 y resuscitation, 2.3 +/- 0.2; extracorporeal cardiopulmonary resuscitation with carbon monoxide appli

249 Cardiopulmonary resuscitation with extracorporeal circul

250 phrine administration as bolus (e.g., during cardiopulmonary resuscitation), were excluded.

251 or return of circulation via extracorporeal cardiopulmonary resuscitation).

252 stomy, gastrostomy, artificial nutrition, or cardiopulmonary resuscitation); however, it was associat

253 strategies (hippocampus: sham, 0.4 +/- 0.2; cardiopulmonary resuscitation, 1.7 +/- 0.4; extracorpore

254 Of 147 children receiving extracorporeal cardiopulmonary resuscitation, 125 (85.0%) had a preexis

255 y resuscitation, 1.7 +/- 0.4; extracorporeal cardiopulmonary resuscitation, 2.3 +/- 0.2; extracorpore

256 y resuscitation, 2.5 +/- 0.4; extracorporeal cardiopulmonary resuscitation, 2.4 +/- 0.2; CO-E-CPR, 1.

257 0.05) and heme oxygenase-1 (sham, 1 +/- 0.1; cardiopulmonary resuscitation, 2.5 +/- 0.4; extracorpore

258 scitation, 426 +/- 169 pg/mL; extracorporeal cardiopulmonary resuscitation, 240 +/- 61 pg/mL; CO-E-CP

259 Caspase-3 activity (cardiopulmonary resuscitation, 426 +/- 169 pg/mL; extrac

260 ment therapy, extracorporeal life support or cardiopulmonary resuscitation, and appearance of patholo

261 ing ventricular fibrillation cardiac arrest, cardiopulmonary resuscitation, and epinephrine administr

262 anical ventilation, ejection fraction, prior cardiopulmonary resuscitation, and lactate.

263 edications, advanced airways, extracorporeal cardiopulmonary resuscitation, and post-cardiac arrest c

264 c arrest rhythm, witnessed status, bystander cardiopulmonary resuscitation, episode location, epineph

265 this practice poses: termination of advanced cardiopulmonary resuscitation, extension of advanced car

266 he vasopressors, and shockable rhythm during cardiopulmonary resuscitation, hospital level, and socio

267 icular function recovered within 72 hours of cardiopulmonary resuscitation, indicative of myocardial

268 MACE were defined as death, cardiopulmonary resuscitation, life-threatening arrhythm

269 cluding studies that included extracorporeal cardiopulmonary resuscitation, no significant difference

270 of naloxone or flumazenil, nonmechanical or cardiopulmonary resuscitation, or endotracheal intubatio

271 tives to promote cardiac arrest recognition, cardiopulmonary resuscitation, public access defibrillat

272 rdiac arrest centers and dispatcher-assisted cardiopulmonary resuscitation, the role of extracorporea

273 During cardiopulmonary resuscitation, these patients had lower

274 ch on assessing predictors of extracorporeal cardiopulmonary resuscitation-associated brain injury is

275 cal ventilation, vasopressors, dialysis, and cardiopulmonary resuscitation.

276 n patients who have undergone extracorporeal cardiopulmonary resuscitation.

277 ced cardiac arrest followed by 90 seconds of cardiopulmonary resuscitation.

278 onitoring of physiological parameters during cardiopulmonary resuscitation.

279 val to discharge and with markers of quality cardiopulmonary resuscitation.

280 (bradycardia with poor perfusion) requiring cardiopulmonary resuscitation.

281 ts who suffered cardiac arrest and underwent cardiopulmonary resuscitation.

282 to guide resuscitation during uninterrupted cardiopulmonary resuscitation.

283 mild elevation of the head and chest during cardiopulmonary resuscitation.

284 th unfavorable outcomes after extracorporeal cardiopulmonary resuscitation.

285 69.7% male, and 58.0% receiving lay-rescuer cardiopulmonary resuscitation.

286 ypeople and healthcare providers who perform cardiopulmonary resuscitation.

287 for cardiogenic shock, and 3) extracorporeal cardiopulmonary resuscitation.

288 on leak and vehicle were administered during cardiopulmonary resuscitation.

289 ty were highly associated with pre-operative cardiopulmonary resuscitation.

290 to understand the underlying disparities in cardiopulmonary resuscitationdelivery and an unmet cardi

291 pulmonary resuscitationdelivery and an unmet cardiopulmonary resuscitationtraining need in Hispanic c

292 Age, body-mass index, renal status, and cardiopulmonary status affect the choice between pancrea

293 ygenation and other modalities of mechanical cardiopulmonary support are increasingly being utilized

294 data and previous experience with artificial cardiopulmonary support strategies, particularly in the

295 er with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS), with mortality rates of

296 agic fever with renal syndrome or hantavirus cardiopulmonary syndrome.

297 However, the effects of TRAP on the cardiopulmonary system in most animal studies have been

298 ECG, 2D echocardiography, cardiopulmonary test, and cardiac magnetic resonance wer

299 C1, HDAC2, HDAC3 and HDAC8) was performed in cardiopulmonary tissues and adventitial fibroblasts isol

300 concentration([Lac](blood)) is a function of cardiopulmonary variables, exercise intensity and some a